Sign in
Back
Estrogen Receptor Expression and Docetaxel Efficacy in Patients with Metastatic Breast Cancer: A Pooled Analysis of Four Randomized Trials
Journal article   Open access  Peer reviewed

Estrogen Receptor Expression and Docetaxel Efficacy in Patients with Metastatic Breast Cancer: A Pooled Analysis of Four Randomized Trials

Fabrice Andre, Kristine Broglio, Lajos Pusztai, Narjiss Berrada, John R. Mackey, Jean Marc Nabholtz, Stephen Chan and Gabriel N. Hortobagyi
The oncologist (Dayton, Ohio), Vol.15(5), pp.476-483
05/2010
DOI: https://doi.org/10.1634/theoncologist.2009-0150
PMCID: PMC3227977
PMID: 20421265

Abstract

Breast Cancer Docetaxel Estrogen receptor Metastasis
The present study assessed the efficacy of docetaxel in patients with metastatic breast cancer according to estrogen receptor expression. Docetaxel produced a higher response rate and lower risk for disease progression to a statistically similar extent regardless of estrogen receptor expression in patients with metastatic breast cancer.
url
https://doi.org/10.1634/theoncologist.2009-0150View
Published (Version of record) Open

Metrics

1 Record Views

Details